In a regulatory filing, Centessa (CNTA) Pharmaceuticals CEO Saurabh Saha disclosed the sale of 55,000 ordinary shares of the company on December 20 at a price of $17.4374 per share.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNTA: